In-utero Selective Serotonin Reuptake Inhibitor Antidepressant Exposure: Fetal Programing and Developmental Interactions With Context

Clin Pharmacol Ther. 2018 Oct;104(4):616-618. doi: 10.1002/cpt.1134. Epub 2018 Jul 27.

Authors

Mina Park^{1

2}, Tim F Oberlander^{1

2

3}

Affiliations

¹ BC Children's Hospital Research Institute, Vancouver, British Columbia, Canada.
² School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
³ Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada.

PMID: 30054914
DOI: 10.1002/cpt.1134

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Age Factors
Animals
Brain / drug effects*
Brain / embryology
Brain / metabolism
Child
Child Behavior / drug effects*
Child Development / drug effects*
Child, Preschool
Depression / diagnosis
Depression / drug therapy*
Depression / psychology
Female
Fetal Development / drug effects*
Gestational Age
Humans
Pregnancy
Prenatal Exposure Delayed Effects*
Risk Assessment
Risk Factors
Selective Serotonin Reuptake Inhibitors / adverse effects*
Serotonin / metabolism
Signal Transduction / drug effects

Substances

Serotonin Uptake Inhibitors
Serotonin

Grants and funding

MOP-5783/CIHR/Canada